Welcome to LookChem.com Sign In|Join Free
  • or
N-[(E)-4-chlorocinnamoyl]-O,O'-dimethyldopamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

356546-36-6

Post Buying Request

356546-36-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

356546-36-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 356546-36-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,6,5,4 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 356546-36:
(8*3)+(7*5)+(6*6)+(5*5)+(4*4)+(3*6)+(2*3)+(1*6)=166
166 % 10 = 6
So 356546-36-6 is a valid CAS Registry Number.

356546-36-6Downstream Products

356546-36-6Relevant academic research and scientific papers

A novel [2 + 2] photodimerization of N-[(E)-3,4-methylenedioxycinnamoyl]dopamine in the solid state.

Ito,Horie,Shindo

, p. 2411 - 2413 (2001)

[reaction: see text] To give photoreactivity to catecholamines, N-cinnamoyl-substituted dopamines (E)-5a-5c and O,O'-dimethyldopamines (E)-3a-3c were prepared under solvent-free conditions. A particularly interesting observed photoreactivity was that of N-[(E)-3,4-methylenedioxycinnamoyl]dopamine ((E)-5c), which underwent a novel type of [2 + 2] photodimerization in the solid state, giving exclusively a tricyclic product 8. This reaction is the first example of solid-state photoaddition of an alkene to the benzene ring.

Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines

Dwivedi, Atma P.,Kumar, Shailesh,Varshney, Vandana,Singh, Amar B.,Srivastava, Arvind K.,Sahu, Devi P.

, p. 2301 - 2305 (2008/09/21)

A series of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines were synthesized and evaluated for their antihyperglycemic activity. Compounds 3g and 6d exhibited lowering of postprandial plasma glucose by 30.7%, 23.3% in SLM and 25.6%, 25.4% in STZ models respectively which is significant compared to metformin and glybenclamide. Other compounds exhibited moderate to good activity ranging from 19.5% to 32.8% in SLM and 3.26% to 25.4% in STZ models.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 356546-36-6